The mutation of DDX3X has been reported in Burkitt lymphoma, chronic lymphocytic leukemia, and natural killer T-cell lymphoma [27,28,29,30,31,32,33,34,35]. Here, DDX3X is linked to B-cell chronic lymphocytic leukemia.